Found 471 investors
Bridgewest Ventures

Bridgewest Ventures

New Zealand

Bridgewest Ventures is a deep tech incubator headquartered in Auckland, New Zealand. The firm seeks to invest in companies operating in the biotechnology, agri-tech, pharmaceuticals, UAV technology, IoT, semiconductor, artificial intelligence, software development, drug discovery and health technology sectors in New Zealand.
Accelerator Incubator

Brooklyn Bridge Ventures

Canada

CDP Capital is a venture capital firm which is out of business. The firm prefers to invest in pre-start up and start up companies. It seeks to invest in the biotechnology, pharmaceuticals, medical instrumentation and information technology sectors.
Venture Capital
Brunnur Ventures

Brunnur Ventures

Iceland

Founded in 2013, Brunnur Ventures is a venture capital firm based in Reykjavik, Iceland. The firm seeks to invest in Icelandic start-ups and growth companies operating within the software, AI, high-tech, Industry 4.0, biotechnology, life sciences, energy technology and gaming sectors.
Venture Capital
Burrill Agbio Capital Fund

Burrill Agbio Capital Fund

San Francisco, California, United States

Burrill Agbio Capital Fund focuses on companies involved in biotechnology, pharmaceuticals, and diagnostics.
Venture Capital
Burrill & Company

Burrill & Company

San Francisco, California, United States

Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.
Biotechnology Finance Venture Capital Private Equity Firm

b.value AG

Germany

Founded in 2016, b.value AG is a venture capital firm based in Dortmund, Germany. The firm seeks to invest during the seed stage in companies operating in the non-pharmaceutical biotechnology and chemistry sectors in the Germany, Austria, and Switzerland regions. The firm focuses on health and nutrition, resource efficiency, and digitization mega-trends.
Venture Capital

BVF Partners

San Francisco, California, United States

BVF Partners San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
Biotechnology Hedge Fund
Cal-X Stars Business Accelerator

Cal-X Stars Business Accelerator

United States

Founded in 2012, Cal-X Stars Business Accelerator is an accelerator based in Los Angeles, California. The firm was formed as a spin out of Leonhardt Ventures. It is focused on the cardiovascular and biotechnology sectors.
Accelerator Incubator
Canelco Capital

Canelco Capital

Finland

Founded in 2009, Canelco Capital is a private equity and venture capital firm headquartered in Helsinki, Finland. The firm specializes in acquisitions and other ownership arrangements of small and medium-sized companies. The firm seeks to invest in a wide range of sectors including information and communication technology, biotechnology, environmental technology, life sciences, mechanical engineering, industrial products and services, healthcare products and services, and energy sectors.
Private Equity Firm

Capital V

United States

Dr. Fred Cohen is a Co-Founder and serves as Senior Advisor and Senior Managing Director at Vida Ventures (Boston). He serves as Board Member at Kadiant. He also served as the Advisor at Mission Bay Capital. Prior to Vida, he was a Partner and founder of TPG Biotechnology, a life science-focused investment effort from 2001-to 2016. From 1980 through 2014, he was at UCSF where he held various clinical responsibilities as a research scientist, an internist for hospitalized patients, a consulting endocrinologist, and the Chief of the Division of Endocrinology and Metabolism. His research interests included structure-based drug design, prion diseases, computational biology, and heteropolymer chemistry. He has published over 200 peer-reviewed articles, participated as a co-inventor on over 10 patents, and has served as an editor or editorial board member of several international scientific journals. He received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his M.D. from Stanford, and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF. He is a Fellow of the American College of Physicians and the American College of Medical Informatics and a member of the American Society for Clinical Investigation and Association of American Physicians. He has received several awards for his work including a Searle Scholarship, Young Investigator Awards from the Endocrine Society and the Western Society for Clinical Investigation, and the LVMH Science pour l'art prize (shared with Stanley Prusiner). He was elected to the Institute of Medicine of the National Academy of Sciences in 2004 and the American Academy of Arts and Sciences in 2008. He currently serves on the Board of Directors of several biotechnology and pharmaceutical organizations including CareDx (NASDAQ: CDNA), Progyny (NASDAQ: PGNY), Veracyte (NASDAQ: VCYT), and UroGen (NASDAQ: URGN). He was Co-Founder and Executive Chairman of Cell Design Labs and a former Director of Quintiles (NYSE: Q), Aptalis Pharma, Rapid Micro Biosystems, Roka (NASDAQ: ROKA), Five Prime Therapeutics (NASDAQ: FPRX), Genomic Health (NASDAQ: GHDX) and Tandem Diabetes (NASDAQ: TNDM).
Individual/Angel
CARB-X

CARB-X

Boston, Massachusetts, United States

CARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, fast diagnostics.
Accelerator
Care Equity

Care Equity

United States

Founded in 2020, Care Equity is a private equity firm headquaterd in New York, New York. The firm seeks to invest in the healthcare, biotechnology, and information technology sectors.
Private Equity Firm
Casdin Capital

Casdin Capital

United States

Founded in 2012, Casdin Capital is a hedge fund manager based in New York, New York. The firm primarily invests in companies operating in the biotechnology, healthcare, life science, information technology and industrial sectors.
Hedge Fund
Cell Innovation Partners

Cell Innovation Partners

Kanagawa, Fukushima, Japan

Cell Innovation Partners is investing in biotechnology companies.
Venture Capital
Central European Biotech Incubator and Accelerator

Central European Biotech Incubator and Accelerator

Austria

Founded in 2018, Central European Biotech Incubator and Accelerator is an accelerator-incubator firm based in Vienna, Austria. The firm seeks to invest in early stage companies. The firm focuses on biotechnology and pharmaceutical sectors which involves developing new medicines and cutting-edge technologies.
Accelerator Incubator
Centre for Cellular And Molecular Platforms

Centre for Cellular And Molecular Platforms

India

Centre for Cellular And Molecular Platforms is a startup accelerator firm based in Bangalore, India. It is an intitiative supported by Department of Biotechnology, Government of India.
Accelerator Incubator

Century HongRong

China

Founded in 2011, Century HongRong is a venture capital firm jointly funded by Guangxi Cross Century Enterprise Group and Zhejiang Hongrong Venture Capital based in Guangxi China. The firm seeks to make investments in sectors like agriculture, large-scale consumption, information technology, biotechnology, etc.
Venture Capital

Charles Dunston

United States

Dr. Michael Ramsey is a Scientific Founder of 908 Devices and serves as its Board Member. He co-founded and served as Board Member at Genturi. He is the Goldby Distinguished Professor of Chemistry at the University of North Carolina - Chapel Hill. Dr. Ramsey is also the director of the UNC Center for Biomedical Microtechnologies, a center focused on fostering collaborations between medical researchers or clinicians and developers of microtechnologies for enhancing access to biological information. His present research interests include highly miniaturized mass spectrometry, micro- and nanofluidics, and single molecule DNA sequencing, single cell assays and point-of-care clinical diagnostic devices. Dr. Ramsey is the sole scientific founder of Caliper Technologies (NASDAQ:CALP), later renamed Caliper Life Sciences and acquired by PerkinElmer in late 2011 for $650M. Caliper is the leading commercial supplier of microfluidic technologies; tools primarily used in the pharmaceutical and biotechnology industries.
Individual/Angel
CHL Medical Partners

CHL Medical Partners

Stamford, Connecticut, United States

CHL Medical Partners, an American venture capital firm, invests in biotechnology, molecular diagnostic, and medical device companies.
Financial Services Medical Venture Capital Venture Capital

Chris Scheppegrell

United States

Mr. Jonas Landstrom served as Investment Manager & Head of Americas at Volvo Group Venture Capital. He has operational experience from a VC backed biotechnology company where he served as Vice President and CFO. He joined Volvo Group Venture Capital in 2010 and sits on the board of several portfolio companies and focuses on investments in the US.
Individual/Angel
Showing 101 to 120 of 471 results